These data indicate that tumour-antigen-specific CD8+ T cells are generated in a time-of-day-dependent manner in the dLN against OVA antigen as well as neoantigen, and similar mechanisms are involved in the subcutaneous and orthotopic engraftment setting. Here, CD8A is linked to neoplasm.